StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

2-(3-Phenoxyphenyl)propionsure

Fenoprofen

HCID 3342
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
29679-58-1
Standard-SMILES
CC(C(=O)O)c1cccc(Oc2ccccc2)c1
InChIKey
RDJGLLICXDHJDY-UHFFFAOYSA-N
Summenformel
C15H14O3
Durchschnittliche Molmasse
242,27 g/mol
Monoisotopische Masse
242,0942943

Überblick

Fenoprofen is a monocarboxylic acid that is propanoic acid in which one of the hydrogens at position 2 is substituted by a 3-phenoxyphenyl group. A non-steroidal anti-inflammatory drug, the dihydrate form of the calcium salt is used for the management of mild to moderate pain and for the relief of pain and inflammation associated with disorders such as arthritis. It is pharmacologically similar to aspirin, but causes less gastrointestinal bleeding. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, an antipyretic, a cyclooxygenase 2 inhibitor, a cyclooxygenase 1 inhibitor and a drug allergen. It is a conjugate acid of a fenoprofen(1-).

Namen und Bezeichner

Bevorzugter Name
Fenoprofen
IUPAC
2-(3-phenoxyphenyl)propanoic acid
Lokaler Name
2-(3-Phenoxyphenyl)propionsure
Englischer Name
2-(3-phenoxyphenyl)propionic acid
Summenformel
C15H14O3
Molmasse
242.27

Namen und Synonyme

fenoprofen2-(3-Phenoxyphenyl)propanoic acid31879-05-7FenoprofeneFenoprofenoFenoprofenumNalfonalpha-Methyl-3-phenoxybenzeneacetic acid(+-)-m-Phenoxyhydratropic acid2-(m-phenoxyphenyl)propionic acid3-Phenoxyhydratropic acidLilly-53858
Weitere Namen anzeigen
Fenoprofen D3Einecs 249-770-12-(3-Phenoxyphenyl)Fenoprofen, racemic mixtureα-Methyl-3-phenoxybenzeneacetic acidBenzeneacetic acid, a-methyl-3-phenoxy-Benzeneacetic acid, α-methyl-3-phenoxy-Benzeneacetic acid, α-methyl-3-phenoxy-
(+-)-2-(3-Phenoxyphenyl)propionic acidalpha-(m-phenoxyphenyl)propionic acidRA33EAC7KYNSC-757813CHEBI:5004DL-2-(3-phenoxyphenyl)propionic acidBenzeneacetic acid, alpha-methyl-3-phenoxy-, (+-)-DTXSID9023045

Datenbank-Bezeichner

CAS

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
3,3
Polarare Oberfläche (TPSA)
46,5 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
4
Schwere Atome
18
Formalladung
0
Komplexität
271

Experimentelle und physikochemische Eigenschaften

LogP · 2 Einträge

3.1

3.45

Color/FormVISCOUS OIL
Solubility · 2 Einträge

Slight (calcium salt)

8.11e-02 g/L

Human Drugs · 2 Einträge

Breast Feeding; Lactation; Milk, Human; Analgesic Agents; Anti-inflammatory Agents, Nonsteroidal

Pharmaceuticals

Boiling Point168-171 °C @ 0.11 MM HG
Melting Point168-171
Refractive IndexINDEX OF REFRACTION: 1.5742 @ 25 °C/D
Physical DescriptionSolid
Dissociation Constants · 2 Einträge

4.5

PKA= 7.3

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

Toxikologische Informationen

Interactions · 4 Einträge

WHEN FENOPROFEN WAS ADDED TO REGIMEN OF...PT WITH RHEUMATOID ARTHRITIS WHO WERE RECEIVING CORTICOSTEROID OR GOLD THERAPY, THERE WAS SOME EVIDENCE THAT DOSE OF STEROID COULD BE REDUCED & COMBINATION WITH GOLD WAS MORE EFFECTIVE.

FOOD DELAYS ABSORPTION...& REDUCES PEAK PLASMA CONCN (ABOUT 30%) & TOTAL ABSORPTION (ABOUT 20%), AS DOES COADMIN OF...ANTACIDS.

/PLASMA PROTEIN/ BINDING OF FENOPROFEN IS INHIBITED BY CONCOMITANT ADMIN OF INDOMETHACIN & PHENYLBUTAZONE... PLASMA T/2 OF FENOPROFEN IS DECR BY ASPIRIN...

FENPROFEN & PROPOXYPHENE ARE ADDITIVE WHEN GIVEN TOGETHER.

Hepatotoxicity · 1 Eintrag

Prospective studies show that up to 15% of patients taking fenoprofen experience at least transient serum aminotransferase elevations. These elevations are generally transient, mild and asymptomatic, and may resolve even with drug continuation. Marked aminotransferase elevations (above 3 times the upper limit of normal (ULN) occur in less than 1% of patients.

Human Toxicity Excerpts · 5 Einträge

MOST COMMON ADVERSE REACTIONS /ORAL ADMIN/...GI EFFECTS (EG, DYSPEPSIA, CONSTIPATION, NAUSEA, VOMITING)...FEW CASES OF ULCERATION... CNS REACTIONS INCL DROWSINESS, DIZZINESS, HEADACHE, NERVOUSNESS, & CONFUSION. PRURITUS, RASH, SWEATING, PALPITATIONS, TREMOR, TINNITUS, BLURRED VISION, & DECR HEARING...SENSITIVITY TO DRUG...

ELEVATIONS OF SERUM TRANSAMINASE, LACTIC DEHYDROGENASE, & ALKALINE PHOSPHATASE LEVELS...IN SOME PT. DECR IN HEMOGLOBIN & HEMATOCRIT...OCCASIONALLY. FENOPROFEN REDUCES PLATELET AGGREGATION & ADHESIVENESS & INCR BLEEDING TIME /ORAL ADMIN/.

.../FENOPROFEN, ORALLY/ EFFECTIVENESS IN RHEUMATOID ARTHRITIS APPEARS... COMPARABLE TO...ASPIRIN &...INCIDENCE OF GI REACTIONS & AMT OF GI BLEEDING IS LESS THAN WITH ASPIRIN.

...DRUGS /INCL FENOPROFEN/ HAVE BEEN ASSOC WITH FATAL GI HEMORRHAGE IN RARE CASES.

For more Human Toxicity Excerpts (Complete) data for FENOPROFEN (10 total), please visit the HSDB record page.

Drug Induced Liver Injury

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

M - Musculo-skeletal system

QM - Musculo-skeletal system

Protein Binding99% to albumin.
Pharmacodynamics · 1 Eintrag

Fenoprofen is a propionic acid derivative with analgesic, antiinflammatory and antipyretic properties. Fenoprofen inhibits prostaglandin synthesis by decreasing the enzyme needed for biosynthesis. In patients with rheumatoid arthritis, the anti-inflammatory action of fenoprofen has been evidenced by relief of pain, increase in grip strength, and reductions in joint swelling, duration of morning stiffness, and disease activity (as assessed by both the investigator and the patient). In patients with osteoarthritis, the anti-inflammatory and analgesic effects of fenoprofen have been demonstrated by reduction in tenderness as a response to pressure and reductions in night pain, stiffness, swelling, and overall disease activity (as assessed by both the patient and the investigator). These effects have also been demonstrated by relief of pain with motion and at rest and increased range of motion in involved joints. In patients with rheumatoid arthritis and osteoarthritis, clinical studies have shown fenoprofen to be comparable to aspirin in controlling the aforementioned measures of disease activity, but mild gastrointestinal reactions (nausea, dyspepsia) and tinnitus occurred less frequently in patients treated with fenoprofen than in aspirin-treated patients. It is not known whether fenoprofen causes less peptic ulceration than does aspirin. In patients with pain, the analgesic action of fenoprofen has produced a reduction in pain intensity, an increase in pain relief, improvement in total analgesia scores, and a sustained analgesic effect.

Mechanism of Action · 2 Einträge

Fenoprofen's exact mode of action is unknown, but it is thought that prostaglandin synthetase inhibition is involved. Fenoprofen has been shown to inhibit prostaglandin synthetase isolated from bovine seminal vesicles.

LIKE ASPIRIN, FENOPROFEN INHIBITS PROSTAGLANDIN SYNTHETASE, BUT SIGNIFICANCE OF THIS ACTION IN RELATION TO CLINICAL EFFECTS PRODUCED IS NOT KNOWN.

Biological Half-Life · 3 Einträge

Zugehörige Reaktionen

34
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 317727
HRID 317727als Produkt
Reaktionsgleichung von HRID 358284
HRID 358284als Produkt
Reaktionsgleichung von HRID 358285
HRID 358285als Produkt
Reaktionsgleichung von HRID 442230
HRID 442230als Edukt
Reaktionsgleichung von HRID 461426
HRID 461426als Edukt
Reaktionsgleichung von HRID 614262
HRID 614262als Produkt
Reaktionsgleichung von HRID 614657
HRID 614657als Edukt
Reaktionsgleichung von HRID 662292
HRID 662292als Produkt
ZurückSeite 1 von 5

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
29679-58-1、31879-05-7、34597-40-5
PubChem CID
3342
DTXSID
DTXSID9023045
ChEMBL
CHEMBL1297
ChEBI
CHEBI:5004
UNII
RA33EAC7KY
EC Number
249-770-1、250-850-3
Nikkaji
J286.928D
Collision Cross Section
159.56 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Siedepunkt
168 · 168-171 °C(Press: 0.11 Torr)
Dichte
1.183 · 1.183±0.06 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
Löslichkeit
100 mg/mL · DMSO : 100 mg/mL (412.76 mM; Need ultrasonic)
pka
4.2 · 4.20±0.10(Predicted)
Aggregatzustand
Oil to Thick Oil
Farbe
Colourless
EPA chemische Informationen
-3 · Benzeneacetic acid, ?-methyl-3-phenoxy- (29679-58-1)
· 6 Einträge

Benchmark Dataset for the Liver Toxicity Knowledge Base (LTKB)

fenoprofen

Nalfon®

NSAIDs

8

most-DILI-concern

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
EPA Human Health Benchmarks for Pharmaceuticals · 6 Einträge

Fenoprofen

18.6

78.9

For the treatment of mild to moderate pain, the recommended dosage is 200 mg given orally every 4 to 6 hours, as needed.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 800 mg/day, Lowest Therapeutic Dose (LTD): 10.0 mg/kg-day, and Screening Dose: 0.003 mg/kg-day.

8-Jun-16

Sicherheitsdaten

hs_code
2918999090

Plasma half-life is approximately 3 hours.

...RAPIDLY ABSORBED AFTER ORAL ADMIN; PEAK PLASMA LEVEL OCCURS WITHIN 90 MIN. IT HAS PLASMA T/2 OF ABOUT 160 MIN, WHICH DOES NOT APPEAR...DOSE DEPENDENT. ABSORPTION & AVAILABILITY ARE REDUCED WHEN...AGENT IS GIVEN WITH FOOD, BUT ARE NOT AFFECTED BY CONCOMITANT ADMIN OF AN ANTACID...

...T/2...2.5-3 HR...

Metabolism/Metabolites · 3 Einträge

About 90% of a single oral dose is eliminated within 24 hours as fenoprofen glucuronide and 4'-hydroxyfenoprofen glucuronide, the major urinary metabolites of fenoprofen.

...FENOPROFEN...FOUND TO YIELD 2 URINARY GLUCURONIDES IN MAN. ONE...ACCOUNTING FOR ALMOST 1/2 THE DOSE, IS THE ACYL GLUCURONIDE... THE SECOND...ACCOUNTING FOR THE OTHER 1/2 OF THE DOSE, IS A GLUCURONIDE OF THE PHENOLIC DERIVATIVE /OF FENOPROFEN/...AN ACYL GLUCURONIDE WITH A FREE PHENOLIC GROUP.

...FENOPROFEN...FOUND TO YIELD SMALL AMT OF ACID-LABILE CONJUGATE BEING NEITHER A GLYCINE NOR A GLUTAMINE CONJUGATE...

FDA Pharmacological Classification · 6 Einträge

RA33EAC7KY

FENOPROFEN

Mechanisms of Action [MoA] - Cyclooxygenase Inhibitors

Chemical Structure [CS] - Anti-Inflammatory Agents, Non-Steroidal

Established Pharmacologic Class [EPC] - Nonsteroidal Anti-inflammatory Drug

Fenoprofen is a Nonsteroidal Anti-inflammatory Drug. The mechanism of action of fenoprofen is as a Cyclooxygenase Inhibitor.

MeSH Pharmacological Classification · 2 Einträge

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.

Absorption, Distribution and Excretion · 6 Einträge

Rapidly absorbed under fasting conditions, and peak plasma levels of 50 µg/mL are achieved within 2 hours after oral administration of 600 mg doses.

...RAPIDLY ABSORBED AFTER ORAL ADMIN; PEAK PLASMA LEVEL OCCURS WITHIN 90 MIN. ...ABSORPTION & AVAILABILITY ARE REDUCED WHEN...AGENT IS GIVEN WITH FOOD, BUT ARE NOT AFFECTED BY CONCOMITANT ADMIN OF AN ANTACID...

...FENOPROFEN...IS WELL ABSORBED FROM GI TRACT AS NA OR CA SALT, & IS RAPIDLY CLEARED BY KIDNEYS...

IN USUAL DOSES, FENOPROFEN...WELL ABSORBED (OVER 80%), RAPIDLY /ACHIEVES/... STEADY-STATE BLOOD LEVELS...HIGHLY PROTEIN BOUND (95-99%). ...BIOTRANSFORMED IN LIVER, & METABOLITES ARE EXCRETED IN URINE. ...T/2...2.5-3 HR...

FOLLOWING ABSORPTION, FENOPROFEN IS METAB & EXCRETED ALMOST EXCLUSIVELY IN URINE IN CONJUGATED FORM. ...IS HIGHLY BOUND TO PLASMA PROTEIN, & IT MAY DISPLACE OTHER PROTEIN-BOUND DRUGS FROM THEIR BINDING SITES, LEADING TO DRUG INTERACTIONS.

HUMAN PLASMA & URINE PHARMACOKINETICS AFTER ORAL & IV ADMIN OF FENOPROFEN.

Cellular LocationsCytoplasm
Metabolite PathwaysFenoprofen Action Pathway

Verwendung und Herstellung

UsesMEDICATION
Methods of ManufacturingMARSHALL, FRENCH PATENT 2,015,718 CORRESPONDING TO US PATENT 3,600,437 (1970, 1971 TO LILLY).
Formulations/Preparations · 2 Einträge

LILLY 69323; FENOPRON; FEPRONA /CALCIUM SALT DIHYDRATE/

NALFON (DISTA). ORAL: CAPSULES 300 MG

Use ClassificationPharmaceuticals

Anwendungen

VerwendenFenoprofen is a positive allosteric modulators at melanocortin receptor 3 for treatment of inflammatory diseases in human and mouse model.